Marshall Wace, LLP 908 Devices Inc. Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.0 - $7.24 $221,980 - $321,427	44,396 New	44,396 $228,000
Q1 2023 May 15, 2023	BUY	$6.61 - $10.66 $140,158 - $226,034	21,204 New	21,204 $182,000
Q3 2022 Nov 14, 2022	BUY	$15.18 - $24.99 $808,851 - $1.33 Million	53,284 New	53,284 $876,000
Q1 2022 May 16, 2022	SELL	$13.18 - $26.28 $18,741 - $37,370	-1,422 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$23.17 - $38.77 $820,519 - $1.37 Million	-35,413 Reduced 96.14%	1,422 $37,000
Q3 2021 Nov 15, 2021	BUY	$29.99 - $39.13 $948,103 - $1.24 Million	31,614 Added 605.52%	36,835 $1.2 Million
Q2 2021 Aug 13, 2021	SELL	$36.7 - $55.11 $1.89 Million - $2.84 Million	-51,549 Reduced 90.8%	5,221 $202,000
Q1 2021 May 17, 2021	BUY	$39.94 - $75.0 $906,278 - $1.7 Million	22,691 Added 66.58%	56,770 $2.75 Million
Q4 2020 Feb 16, 2021	BUY	$49.0 - $67.92 $1.67 Million - $2.31 Million	34,079 New	34,079 $1.94 Million

18.4M

14.1K

22K

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $61.3M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.